Fortunately, the technology, the pharmaceutical industry, public policy and health has advanced in recent years, giving greater life expectancy to the immunodeficient.
The social networks have made wide dissemination, world conferences, campaigns and other effective has helped much in the spread, as well as in the awareness of those who provide services.
The immune globulin and gammaglobulin has brought benefits without many adverse reactions